Myriad Genetics grants Fox 39,370 stock units
Each restricted stock unit is a contingent right to receive one share of Myriad common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Myriad Genetics Inc. (MYGN) granted Chief Legal & Corp Strategy officer Jennifer Lynne Fox 39,370 time-based restricted stock units on November 1, 2026, under its 2026 Employee, Director and Consultant Equity Incentive Plan. Her reported direct position following the award was 345,334 shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 39,370 | $0.00 | $0.00 |
Footnotes (1)
- F1. Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.
Key Figures
Key Terms
time-based restricted stock units financial
contingent right financial
vests in three equal annual installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many restricted stock units did Jennifer Lynne Fox receive from MYGN?
How do Jennifer Lynne Fox’s MYGN restricted stock units vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.